Notice |
How to write your comments onto a webpage
[2]
| 2016.07.06 | 운영자 | 2016.11.20 | 18193 |
Notice |
How to Upload Pictures in webpages
| 2016.07.06 | 운영자 | 2018.10.19 | 32346 |
Notice |
How to use Rich Text Editor
[3]
| 2016.06.28 | 운영자 | 2018.10.19 | 5922 |
Notice |
How to Write a Webpage
| 2016.06.28 | 운영자 | 2020.12.23 | 43839 |
543 |
[Medical] The Obesity Paradox
[4] | 2012.10.24 | 이한중*65 | 2012.10.24 | 5890 |
542 |
[Medical Column] 6. 조기수축
| 2011.07.18 | 이종구*57 | 2011.07.18 | 5846 |
541 |
Chronic Fatigue Syndrome - Viral origin ?
[5] | 2009.10.09 | 운영자 | 2009.10.09 | 5837 |
540 |
[Medical Column] 음주와 건강
[2] | 2012.07.20 | 이종구*57 | 2012.07.20 | 5712 |
539 |
A Secret For Long Life?
[7] | 2010.12.31 | 이한중*65 | 2010.12.31 | 5617 |
538 |
[Medical] Dietary Supplements and Mortality Rate
[1] | 2012.03.08 | 이한중*65 | 2012.03.08 | 5561 |
537 |
[Medical Column] 3. 심근경색증 - 1
| 2011.06.20 | 이종구*57 | 2011.06.20 | 5409 |
536 |
[Medical] Sleep and Heart
[1] | 2012.04.26 | 이한중*65 | 2012.04.26 | 5381 |
535 |
[Medical Column] 2. 협심증은 어떤 병인가
| 2011.06.01 | 운영자 | 2011.06.01 | 5274 |
534 |
[Medical] Heavy Thoughts and One Very Bad Apple
[1] | 2012.09.02 | 이한중*65 | 2012.09.02 | 5217 |
533 |
[Medical]Radiation Treatment for Intractable VT, Not Cancer
[3] | 2017.12.13 | 이한중*65 | 2017.12.14 | 5194 |
532 |
Heart Attacks Are Silent Haft of the Time
[2] | 2016.08.07 | 이한중*65 | 2016.08.07 | 5191 |
531 |
[Medical Column] 1. 관상동맥질환이란
[1] | 2011.05.27 | 이종구*57 | 2011.05.27 | 5070 |
530 |
[Medical Column] 8. 발작성 빈맥
| 2011.08.06 | 이종구*57 | 2011.08.06 | 5068 |
529 |
[Medical] Nocturia Management and Antidiuretic Pharmacotherapy
[1] | 2014.05.16 | 이한중*65 | 2014.05.16 | 4982 |
528 |
[Medical Column] 4. 심근경색증-3
| 2011.07.02 | 이종구*57 | 2011.07.02 | 4967 |
527 |
[Medical Column] 5. 부정맥의 이해
| 2011.07.08 | 이종구*57 | 2011.07.08 | 4949 |
526 |
[Medical Column] 12. 심부전증 -2
| 2011.09.22 | 이종구*57 | 2011.09.22 | 4874 |
525 |
[Medical Column] 3. 협심증은 어떻게 진단하는가
| 2011.06.03 | 운영자 | 2011.06.03 | 4853 |
524 |
[Medical Column] 9. 실신하는 사람들
| 2011.08.16 | 이종구*57 | 2011.08.16 | 4846 |
According to Biogen, this anti-amyloid, monoclonal antibody, Aducanumab
in the latest phase 3 trial turned out to be a winner for Alzheimer's as described in this article.
After discussing with FDA, Biogen is planning to apply for approval for the patients.
This agent will be the first such drug giving some hope for the patients.